Search research articles
Contact Us
Filters
Showing results (41-50 of 149) with videos related to
Page
of 15
Sort By:
Journal of Cancer Research and Clinical Oncology
|
October 2, 2024
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment
Stefan S Bielack, Carole Soussain, Christopher P Fox, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
Francisco Bautista, Dan Engelhard, Carmelo Rizzari, et al.
Oncotarget
|
October 16, 2013
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Riccardo Masetti, Marco Togni, Annalisa Astolfi, et al.
Pediatric Blood & Cancer
|
September 11, 2007
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia
Silvia Einaudi, Nicoletta Bertorello, Nicoletta Masera, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
August 5, 2018
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency
Francesco Saettini, Daniele Moratto, Andrea Grioni, et al.
Hematology Reports
|
October 16, 2014
Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment
Carmelo Rizzari, Maria Caterina Putti, Antonella Colombini, et al.
British Journal of Haematology
|
September 30, 2017
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia
Matteo Zampini, Valeria Bisio, Anna Leszl, et al.
Cancers
|
October 29, 2025
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials
Nicolò Peccatori, Erica Brivio, Andrej Lissat, et al.
Pediatric Blood & Cancer
|
March 27, 2026
When Neuromuscular Weakness Is Not Chemotherapy‑Related: Spinal Muscular Atrophy Type II Diagnosed After Acute Lymphoblastic Leukemia Onset in a 1-Year-Old Child: A Case Report and Review of the Literature
Francesca Romani, Francesca Cattaneo, Emanuele Villa, et al.
Frontiers in Oncology
|
May 18, 2026
Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report
Grazia Fazio, Jari Intra, Orsola Montini, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 149) with videos related to
Sort By:
Page
of 15
Journal of Cancer Research and Clinical Oncology
|
October 2, 2024
A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment
Stefan S Bielack, Carole Soussain, Christopher P Fox, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
Francisco Bautista, Dan Engelhard, Carmelo Rizzari, et al.
Oncotarget
|
October 16, 2013
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia
Riccardo Masetti, Marco Togni, Annalisa Astolfi, et al.
Pediatric Blood & Cancer
|
September 11, 2007
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia
Silvia Einaudi, Nicoletta Bertorello, Nicoletta Masera, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
August 5, 2018
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency
Francesco Saettini, Daniele Moratto, Andrea Grioni, et al.
Hematology Reports
|
October 16, 2014
Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment
Carmelo Rizzari, Maria Caterina Putti, Antonella Colombini, et al.
British Journal of Haematology
|
September 30, 2017
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia
Matteo Zampini, Valeria Bisio, Anna Leszl, et al.
Cancers
|
October 29, 2025
Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials
Nicolò Peccatori, Erica Brivio, Andrej Lissat, et al.
Pediatric Blood & Cancer
|
March 27, 2026
When Neuromuscular Weakness Is Not Chemotherapy‑Related: Spinal Muscular Atrophy Type II Diagnosed After Acute Lymphoblastic Leukemia Onset in a 1-Year-Old Child: A Case Report and Review of the Literature
Francesca Romani, Francesca Cattaneo, Emanuele Villa, et al.
Frontiers in Oncology
|
May 18, 2026
Is creatine kinase a valid aid in early cardiac muscle damage detection during treatment for childhood acute lymphoblastic leukemia? A case report
Grazia Fazio, Jari Intra, Orsola Montini, et al.
Page
of 15